Neotegojeong 25 mg (Tegoprazan)

Adult dose

1. Treatment of erosive gastroesophageal reflux disease Administer 50 mg orally once daily for 4 weeks. For patients whose esophagitis has not healed or whose symptoms persist, administer for an additional 4 weeks. 2. Treatment of non-erosive gastroesophageal reflux disease Administer 50 mg orally once daily for 4 weeks. 3. Treatment of gastric ulcers Administer 50 mg orally once daily for 8 weeks. 4. Concomitant antibiotic therapy for Helicobacter pylori eradication in patients with peptic ulcers and/or chronic atrophic gastritis Patients with Helicobacter pylori infection should receive eradication therapy. Administer this medicine 50 mg with amoxicillin 1 g and clarithromycin 500 mg orally twice daily for 7 days. 5. Maintenance treatment after treatment of erosive gastroesophageal reflux disease <limited to 25mg> Administer 25 mg orally once daily. This medicine may be taken with or without food.

This medication should not be used in patients with a known allergy to this medication or its ingredients, or who have shown hypersensitivity to benzimidazole class drugs. Additionally, this medication should not be administered to patients taking medications containing atazanavir, nelfinavir, or rilpivirine. It is safest to refrain from using this medication during pregnancy or breastfeeding. Caution should be exercised in patients with liver or kidney dysfunction, as well as in the elderly. While taking this medication, gastrointestinal side effects such as nausea, diarrhea, and dyspepsia may occur, as well as neurological symptoms like headache and dizziness. Occasionally, symptoms such as skin rash, fatigue, and myalgia have also been reported, so consult a physician if any unusual symptoms arise. Long-term use of this medication may lead to vitamin B12 deficiency, thus regular monitoring is needed. Prolonged use may increase the risk of gastric polyps or osteoporosis-related fractures, so it is recommended to use the minimum effective dose and duration. Additionally, prolonged use may result in hypomagnesemia, hence magnesium levels should be periodically checked. This medication suppresses gastric acid secretion, which may increase the risk of certain bacterial infections, so inform medical personnel if symptoms such as diarrhea persist. While no specific effects have been reported when driving or operating machinery, caution is advised based on individual conditions. This medication may interact with other drugs, so be sure to inform your healthcare provider of any medications being taken. Safety in children and adolescents has not been established, so caution is necessary.

• Nausea
• diarrhea
• indigestion
• nasopharyngitis
• viral upper respiratory infection
• chest discomfort
• upper abdominal pain
• abdominal discomfort
• constipation
• abdominal pain

This medication may be sensitive to air or moisture, so it should be stored in a tightly sealed container. It is recommended to maintain a storage temperature between 1 and 30 degrees Celsius at room temperature. This helps to maintain the medication's effectiveness and safety.

Appearance

Pale pink oval film-coated tablet

Package unit

30 tablets/bottle, 300 tablets/bottle